Cover Image
市場調查報告書

敗血症診斷的全球市場預測 2023年:微生物學、分子診斷、免疫檢測、流式細胞技術、微流體動態、生物標記

Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 371000
出版日期 內容資訊 英文 194 Pages
訂單完成後即時交付
價格
Back to Top
敗血症診斷的全球市場預測 2023年:微生物學、分子診斷、免疫檢測、流式細胞技術、微流體動態、生物標記 Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023
出版日期: 2018年04月05日 內容資訊: 英文 194 Pages
簡介

全球敗血症診斷的市場規模,預計從2018年的3億9,660萬美元到2023年擴大到6億1,390萬美元,期間為9.1%的年複合成長率 (CAGR) 。敗血症發病率的增加,老年人口的增加,手術數的增加,院內感染的發病率高,及各種已經過核准敗血症診斷設備的市售化、可用性,預計促進在預測期間內的市場。可是,對敗血症的確立的醫療費償付政策及高額的自動診斷設備,成為抑制該市場成長的主要原因。

本報告提供全球敗血症診斷市場相關分析,市場基本結構,主要市場促進、阻礙因素,各市場區隔 (技術、產品、手法、病原體、檢驗類型、終端用戶)的詳細的分析,各地區的詳細趨勢,市場競爭的狀態,主要企業的簡介等調查、考察。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 重要考察

  • 敗血症診斷:市場規模
  • 敗血症診斷市場:各技術
  • 地區分析:敗血症診斷市場,各產品、地區
  • 敗血症診斷市場:各病原體
  • 敗血症診斷市場:各手法
  • 敗血症診斷市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 課題

第6章 敗血症診斷市場:各技術

  • 簡介
  • 微生物學
  • 分子診斷
    • 聚合酵素鏈鎖反應
    • 肽核酸螢光原位雜交計數系統 (PNA FISH)
    • 微陣列、其他
  • 免疫檢測
  • 流式細胞技術
  • 微流體動態
  • 生物標記

第7章 敗血症診斷市場:各產品

  • 簡介
  • 設備
  • 血液培養基
  • 化驗 & 試劑
  • 軟體

第8章 敗血症診斷市場:各手法

  • 簡介
  • 傳統診斷
  • 自動化診斷

第9章 敗血症診斷市場:各病原體

  • 簡介
  • 細菌性敗血症
    • 革蘭氏陰性菌敗血症
    • 克陽性菌敗血症
  • 真菌性敗血症
  • 其他病原體感染

第10章 敗血症診斷市場:各檢驗類型

  • 簡介
  • 實驗室檢驗
  • 照護現場 (POS) 檢驗

第11章 敗血症診斷市場:各終端用戶

  • 簡介
  • 醫院
  • 病理檢驗室、參考檢驗室

第12章 敗血症診斷市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他的歐洲 (ROE)
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他的亞太地區
  • 其他 (RoW)
    • 南美
    • 中東、非洲

第14章 企業簡介

  • BIOMERIEUX SA
  • T2 BIOSYSTEMS
  • LUMINEX
  • BECTON, DICKINSON, AND COMPANY (BD)
  • ROCHE DIAGNOSTICS (F. HOFFMANN-LA ROCHE LTD.子公司)
  • DANAHER
  • THERMO FISHER SCIENTIFIC
  • BRUKER
  • ABBOTT
  • IMMUNEXPRESS
  • RESPONSE BIOMEDICAL
  • AXIS-SHIELD DIAGNOSTICS
  • CYTOSORBENTS
  • MITSUBISHI CHEMICAL EUROPE
  • EKF DIAGNOSTICS

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 4575

"The sepsis diagnostics market projected to grow at a CAGR of 9.1%."

The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and commercialization and availability of a wide variety of approved sepsis diagnostic devices are the factors expected to drive the market during the study period. However, the lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are the major factors restraining the growth of this market.

"Microbiology to command the largest share of the sepsis diagnostics market in 2018."

On the basis of technology, the microbiology segment is expected to command the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the growing use of blood culture techniques for the diagnosis of sepsis.

"The blood culture media segment is expected to be the fastest-growing segment during the forecast period."

On the basis of products, the market is segmented into blood culture media, instruments, assays & reagents, and software. The blood culture media segment is expected to be the fastest-growing segment during the forecast period. The large share of this segment can be attributed to the fact that blood culture testing is used as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.

"Asia Pacific is expected grow at the highest CAGR during the forecast period."

Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period due to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 - 30%, Tier 2 - 55% and Tier 3 - 15%
  • By Designation - C-level - 30%, Director-level - 35%, Others - 35%
  • By Region - North America - 55%, Europe - 15%, APAC - 25%, RoW - 5%

The major players of the sepsis diagnostics market are: bioMerieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).

Research Coverage:

This report studies the sepsis diagnostics market based on technology, product, pathogen, test type, method, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis- market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
  • 1.4. MARKETS COVERED
    • 1.4.1. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
    • 2.1.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.1.4. BOTTOM-UP APPROACH
    • 2.1.5. TOP-DOWN APPROACH
    • 2.1.6. RESEARCH DESIGN
    • 2.1.7. MARKET DATA VALIDATION AND TRIANGULATION
    • 2.1.8. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. SEPSIS DIAGNOSTICS: MARKET OVERVIEW
  • 4.2. SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY
  • 4.3. GEOGRAPHIC ANALYSIS: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT AND REGION
  • 4.4. SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN
  • 4.5. SEPSIS DIAGNOSTICS MARKET, BY METHOD
  • 4.6. GEOGRAPHIC SNAPSHOT OF THE SEPSIS DIAGNOSTICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence of sepsis in the adult population
      • 5.2.1.1. Increasing incidence of sepsis in neonates
      • 5.2.1.2. Growing incidence of hospital-acquired infections
      • 5.2.1.3. Increasing number of surgical procedures
      • 5.2.1.4. Increasing burden of pneumonia
      • 5.2.1.5. Influx of novel sepsis diagnostic products
      • 5.2.1.6. Rising initiatives to increase the awareness and drive the adoption of sepsis diagnostic tests
      • 5.2.1.7. Funding for sepsis-related research activities
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Lack of established reimbursement policies for sepsis
      • 5.2.2.2. High cost of automated diagnostic devices
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Development of rapid diagnostic/POC techniques for early sepsis diagnosis
      • 5.2.3.2. Evolution of novel biomarkers for sepsis diagnosis
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of standard protocols and awareness for sepsis diagnosis and treatment
      • 5.2.4.2. Shortage of skilled healthcare professionals

6. SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. MICROBIOLOGY
  • 6.3. MOLECULAR DIAGNOSTICS
    • 6.3.1. POLYMERASE CHAIN REACTION
    • 6.3.2. PEPTIDE NUCLEIC ACID-FLUORESCENT IN SITU HYBRIDIZATION
    • 6.3.3. MICROARRAYS
    • 6.3.4. SYNDROMIC PANEL-BASED TESTING
  • 6.4. IMMUNOASSAY
  • 6.5. FLOW CYTOMETRY
  • 6.6. MICROFLUIDICS
  • 6.7. BIOMARKERS

7. SEPSIS DIAGNOSTICS MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. INSTRUMENTS
  • 7.3. BLOOD CULTURE MEDIA
  • 7.4. ASSAYS & REAGENTS
  • 7.5. SOFTWARE

8. SEPSIS DIAGNOSTICS MARKET, BY METHOD

  • 8.1. INTRODUCTION
  • 8.2. CONVENTIONAL DIAGNOSTICS
  • 8.3. AUTOMATED DIAGNOSTICS

9. SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN

  • 9.1. INTRODUCTION
  • 9.2. BACTERIAL SEPSIS
    • 9.2.1. GRAM-NEGATIVE BACTERIAL SEPSIS
    • 9.2.2. GRAM-POSITIVE BACTERIAL SEPSIS
  • 9.3. FUNGAL SEPSIS
  • 9.4. OTHER PATHOGENS

10. SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE

  • 10.1. INTRODUCTION
  • 10.2. LABORATORY TESTS
  • 10.3. POINT-OF-CARE TESTS

11. SEPSIS DIAGNOSTICS MARKET, BY END USER

  • 11.1. INTRODUCTION
  • 11.2. HOSPITALS
  • 11.3. PATHOLOGY & REFERENCE LABORATORIES

12. SEPSIS DIAGNOSTICS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. US
    • 12.2.2. CANADA
  • 12.3. EUROPE
    • 12.3.1. GERMANY
    • 12.3.2. FRANCE
    • 12.3.3. UK
    • 12.3.4. REST OF EUROPE (ROE)
  • 12.4. ASIA PACIFIC
    • 12.4.1. JAPAN
    • 12.4.2. CHINA
    • 12.4.3. INDIA
    • 12.4.4. REST OF ASIA PACIFIC
  • 12.5. REST OF THE WORLD
    • 12.5.1. LATIN AMERICA
    • 12.5.2. MIDDLE EAST & AFRICA

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS
  • 13.3. COMPETITIVE SCENARIO
    • 13.3.1. PRODUCT LAUNCHES AND APPROVALS, 2015-2017
    • 13.3.2. PARTNERSHIPS AND COLLABORATIONS, 2015-2018
    • 13.3.3. MERGERS AND ACQUISITIONS

14. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 14.1. BIOMERIEUX
  • 14.2. T2 BIOSYSTEMS
  • 14.3. LUMINEX
  • 14.4. BECTON, DICKINSON, AND COMPANY (BD)
  • 14.5. ROCHE DIAGNOSTICS (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.)
  • 14.6. DANAHER
  • 14.7. THERMO FISHER SCIENTIFIC
  • 14.8. BRUKER
  • 14.9. ABBOTT
  • 14.10. IMMUNEXPRESS
  • 14.11. RESPONSE BIOMEDICAL
  • 14.12. AXIS-SHIELD DIAGNOSTICS
  • 14.13. CYTOSORBENTS
  • 14.14. MITSUBISHI CHEMICAL EUROPE
  • 14.15. EKF DIAGNOSTICS

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. DISCUSSION GUIDE
  • 15.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.4. AVAILABLE CUSTOMIZATIONS
  • 15.5. RELATED REPORTS
  • 15.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 2: MICROBIOLOGY MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 3: MOLECULAR DIAGNOSTICS MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: IMMUNOASSAY MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: FLOW CYTOMETRY MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: MICROFLUIDICS MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: BIOMARKERS MARKET FOR SEPSIS DIAGNOSIS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 9: SEPSIS DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: SEPSIS DIAGNOSTIC BLOOD CULTURE MEDIA MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: SEPSIS DIAGNOSTIC ASSAYS & REAGENTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: SEPSIS DIAGNOSTIC SOFTWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 14: CONVENTIONAL DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: AUTOMATED DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 17: BACTERIAL SEPSIS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 18: BACTERIAL SEPSIS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 19: BACTERIAL CAUSES OF ADULT SEPSIS
  • TABLE 20: BACTERIAL CAUSES OF ADULT SEPSIS
  • TABLE 21: FUNGAL SEPSIS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: OTHER PATHOGENS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 24: LABORATORY POINTERS OF SEPSIS
  • TABLE 25: LABORATORY TESTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 26: POINT-OF-CARE TESTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 28: SEPSIS DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 29: SEPSIS DIAGNOSTICS MARKET FOR PATHOLOGY & REFERENCE LABORATORIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 30: SEPSIS DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 31: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 33: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 34: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 35: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 36: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 38: US: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 39: US: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 40: US: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 41: US: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 42: US: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: US: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 44: CANADA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 45: CANADA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 46: CANADA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 47: CANADA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 48: CANADA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: CANADA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 50: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 52: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 53: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 54: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 55: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: EUROPE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 57: GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 58: GERMANY: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 59: GERMANY: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 60: GERMANY: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 61: GERMANY: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: GERMANY: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 63: FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 64: FRANCE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 65: FRANCE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 66: FRANCE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 67: FRANCE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: FRANCE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: UK: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 70: UK: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 71: UK: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 72: UK: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 73: UK: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: UK: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 75: ROE: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 76: ROE: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 77: ROE: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 78: ROE: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 79: ROE: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: ROE: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: APAC: SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 82: APAC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 83: APAC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 84: APAC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 85: APAC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 86: APAC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: APAC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 88: JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 89: JAPAN: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 90: JAPAN: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 91: JAPAN: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 92: JAPAN: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: JAPAN: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 94: CHINA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 95: CHINA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 96: CHINA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 97: CHINA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 98: CHINA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: CHINA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 100: INDIA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 101: INDIA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 102: INDIA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 103: INDIA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 104: INDIA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 105: INDIA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 107: ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 108: ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 109: ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 110: ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: ROAPAC: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 112: ROW: SEPSIS DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 113: ROW: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 114: ROW: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 115: ROW: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 116: ROW: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 117: ROW: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: ROW: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 119: LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 120: LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 121: LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 122: LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 123: LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 124: LATIN AMERICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 125: MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 126: MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2016-2023 (USD MILLION)
  • TABLE 127: MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2016-2023 (USD MILLION)
  • TABLE 128: MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2016-2023 (USD MILLION)
  • TABLE 129: MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: MIDDLE EAST & AFRICA: SEPSIS DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL SEPSIS DIAGNOSTICS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, 2018
  • FIGURE 5: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, 2023
  • FIGURE 6: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY METHOD, 2018
  • FIGURE 7: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TEST TYPE, 2018 VS. 2023
  • FIGURE 8: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, 2018
  • FIGURE 9: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY END USER, 2018
  • FIGURE 10: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY REGION, 2018 (USD MILLION)
  • FIGURE 11: RISING PREVALENCE OF SEPSIS IS DRIVING THE GROWTH OF SEPSIS DIAGNOSTICS MARKET ACROSS THE GLOBE
  • FIGURE 12: MICROBIOLOGY SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2023
  • FIGURE 13: BLOOD CULTURE MEDIA SEGMENT TO DOMINATE THE GLOBAL SEPSIS DIAGNOSTICS PRODUCTS MARKET IN 2018
  • FIGURE 14: BACTERIAL SEPSIS SEGMENT TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: CONVENTIONAL DIAGNOSTICS METHOD TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: SEPSIS DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: BIOMARKERS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: BLOOD CULTURE MEDIA SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 20: CONVENTIONAL DIAGNOSTICS SEGMENT TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET IN 2023
  • FIGURE 21: BACTERIAL SEPSIS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 22: POINT-OF-CARE TESTS SEGMENT TO GROW AT THE HIGHEST CAGR
  • FIGURE 23: HOSPITALS SEGMENT TO DOMINATE THE SEPSIS DIAGNOSTICS MARKET IN 2023
  • FIGURE 24: SEPSIS INCIDENCE, BY COUNTRY, 2017
  • FIGURE 25: SEPSIS DIAGNOSTICS MARKET: GROWTH FORECAST, BY REGION (2018-2023)
  • FIGURE 26: NORTH AMERICA: SEPSIS DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 27: EUROPE: SEPSIS DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 28: APAC: SEPSIS DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 29: KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE SEPSIS DIAGNOSTICS MARKET, 2015-2017
  • FIGURE 30: SEPSIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYERS, 2016
  • FIGURE 31: BIOMERIEUX: COMPANY SNAPSHOT
  • FIGURE 32: T2 BIOSYSTEMS: COMPANY SNAPSHOT
  • FIGURE 33: LUMINEX: COMPANY SNAPSHOT
  • FIGURE 34: BD: COMPANY SNAPSHOT
  • FIGURE 35: ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • FIGURE 36: DANAHER: COMPANY SNAPSHOT
  • FIGURE 37: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 38: BRUKER: COMPANY SNAPSHOT
  • FIGURE 39: ABBOTT: COMPANY SNAPSHOT
  • FIGURE 40: CYTOSORBENTS: COMPANY SNAPSHOT
  • FIGURE 41: EKF DIAGNOSTICS: COMPANY SNAPSHOT
Back to Top